A team of researchers say they’ve designed a personalized cancer vaccine capable of inducing an immune response that fights off melanoma, the deadliest form of skin cancer, that lasts for several years.
In a study published in the journal Nature Medicine back in January, the scientists examined eight subjects who previously had their melanoma surgically removed, but were still at a high risk of recurrence.
All eight were injected with the experimental vaccine called NeoVax. The results were promising: the researchers found a vaccine-induced immune response in all patients that can “persist over years,” according to the paper.
Read more at:
Harvard Scientists Excited by Results on New Cancer Vaccine
No comments:
Post a Comment